계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Cormorant Asset Management
company
About
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.
- 1 - 10
Highlights
Details
- Industries
- Asset Management,Finance,Financial Services
- Founded date
- Feb 21, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Hedge Fund
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles. The firm also focuses on both public and private market innovative companies in the biotechnology and life sciences marketplace.Cormorant Asset Management was founded in 2013 and is based in Boston, Massachusetts, United States.
Investments
Number of Investments
Number of Lead Investments
21
3
Cormorant Asset Management has made 21 investments. Their most recent investment was on
Aug 12, 2022, when Greenlight Biosciences raised $109M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Aug 12, 2022
Greenlight Biosciences
|
Post-IPO Equity | $109M | Agriculture | — |
|
Apr 19, 2022
Tessera Therapeutics
|
Series C | $300M | Biopharma | — |
|
Feb 16, 2022
Star Therapeutics
|
Series Unknown | $100M | — | |
|
Feb 3, 2022
Greenlight Biosciences
|
Post-IPO Equity | $125.50M | Agriculture | — |
|
Jul 13, 2021
Prime Medicine
|
Series B | $200M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
